United States Ophthalmic Drugs Market Report 2017

October 2017 | 111 pages | ID: UA3DDE35482EN
QYResearch

Abstracts

In this report, the United States Ophthalmic Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Ophthalmic Drugs in these regions, from 2012 to 2022 (forecast).

United States Ophthalmic Drugs market competition by top manufacturers/players, with Ophthalmic Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Pfizer
• Merck
• Glaxosmithkline
• Abbott Laboratories
• Johnson and Johnson
• Bayer
• Shire
• Roche Holding
• Novartis
• Akorn
• Eyemed
• Senju Pharmaceutical
• Sun Pharmaceuticals Industries
• Allergan
• Valeant
• Regeneron
• Eyegate Pharmaceuticals
• Lpath Incorporated
• Santen Pharmaceutical
• Cipla Pharmaceuticals

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Solutions
• Ointments
• Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Ophthalmic Drugs for each application, including

• Hospital Pharmacies
• Online Pharmacies
• Independent Pharmacies & Drug Stores

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Ophthalmic Drugs Market Report 2017

1 OPHTHALMIC DRUGS OVERVIEW

1.1 Product Overview and Scope of Ophthalmic Drugs
1.2 Classification of Ophthalmic Drugs by Product Category
  1.2.1 United States Ophthalmic Drugs Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Ophthalmic Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Solutions
  1.2.4 Ointments
  1.2.5 Other
1.3 United States Ophthalmic Drugs Market by Application/End Users
  1.3.1 United States Ophthalmic Drugs Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospital Pharmacies
  1.3.3 Online Pharmacies
  1.3.4 Independent Pharmacies & Drug Stores
1.4 United States Ophthalmic Drugs Market by Region
  1.4.1 United States Ophthalmic Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Ophthalmic Drugs Status and Prospect (2012-2022)
  1.4.3 Southwest Ophthalmic Drugs Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Ophthalmic Drugs Status and Prospect (2012-2022)
  1.4.5 New England Ophthalmic Drugs Status and Prospect (2012-2022)
  1.4.6 The South Ophthalmic Drugs Status and Prospect (2012-2022)
  1.4.7 The Midwest Ophthalmic Drugs Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Ophthalmic Drugs (2012-2022)
  1.5.1 United States Ophthalmic Drugs Sales and Growth Rate (2012-2022)
  1.5.2 United States Ophthalmic Drugs Revenue and Growth Rate (2012-2022)

2 UNITED STATES OPHTHALMIC DRUGS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Ophthalmic Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Ophthalmic Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Ophthalmic Drugs Average Price by Players/Suppliers (2012-2017)
2.4 United States Ophthalmic Drugs Market Competitive Situation and Trends
  2.4.1 United States Ophthalmic Drugs Market Concentration Rate
  2.4.2 United States Ophthalmic Drugs Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Ophthalmic Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES OPHTHALMIC DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Ophthalmic Drugs Sales and Market Share by Region (2012-2017)
3.2 United States Ophthalmic Drugs Revenue and Market Share by Region (2012-2017)
3.3 United States Ophthalmic Drugs Price by Region (2012-2017)

4 UNITED STATES OPHTHALMIC DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Ophthalmic Drugs Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Ophthalmic Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Ophthalmic Drugs Price by Type (2012-2017)
4.4 United States Ophthalmic Drugs Sales Growth Rate by Type (2012-2017)

5 UNITED STATES OPHTHALMIC DRUGS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Ophthalmic Drugs Sales and Market Share by Application (2012-2017)
5.2 United States Ophthalmic Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES OPHTHALMIC DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Pfizer
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Ophthalmic Drugs Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Pfizer Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Merck
  6.2.2 Ophthalmic Drugs Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Merck Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Glaxosmithkline
  6.3.2 Ophthalmic Drugs Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Glaxosmithkline Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Abbott Laboratories
  6.4.2 Ophthalmic Drugs Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Abbott Laboratories Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Johnson and Johnson
  6.5.2 Ophthalmic Drugs Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Johnson and Johnson Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Bayer
  6.6.2 Ophthalmic Drugs Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Bayer Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Shire
  6.7.2 Ophthalmic Drugs Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Shire Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Roche Holding
  6.8.2 Ophthalmic Drugs Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Roche Holding Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Novartis
  6.9.2 Ophthalmic Drugs Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Novartis Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Akorn
  6.10.2 Ophthalmic Drugs Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Akorn Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Eyemed
6.12 Senju Pharmaceutical
6.13 Sun Pharmaceuticals Industries
6.14 Allergan
6.15 Valeant
6.16 Regeneron
6.17 Eyegate Pharmaceuticals
6.18 Lpath Incorporated
6.19 Santen Pharmaceutical
6.20 Cipla Pharmaceuticals

7 OPHTHALMIC DRUGS MANUFACTURING COST ANALYSIS

7.1 Ophthalmic Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Ophthalmic Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Ophthalmic Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Ophthalmic Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES OPHTHALMIC DRUGS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Ophthalmic Drugs Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Ophthalmic Drugs Sales Volume Forecast by Type (2017-2022)
11.3 United States Ophthalmic Drugs Sales Volume Forecast by Application (2017-2022)
11.4 United States Ophthalmic Drugs Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Ophthalmic Drugs
Figure United States Ophthalmic Drugs Market Size (K Pcs) by Type (2012-2022)
Figure United States Ophthalmic Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Solutions Product Picture
Figure Ointments Product Picture
Figure Other Product Picture
Figure United States Ophthalmic Drugs Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Ophthalmic Drugs by Application in 2016
Figure Hospital Pharmacies Examples
Table Key Downstream Customer in Hospital Pharmacies
Figure Online Pharmacies Examples
Table Key Downstream Customer in Online Pharmacies
Figure Independent Pharmacies & Drug Stores Examples
Table Key Downstream Customer in Independent Pharmacies & Drug Stores
Figure United States Ophthalmic Drugs Market Size (Million USD) by Region (2012-2022)
Figure The West Ophthalmic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Ophthalmic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Ophthalmic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Ophthalmic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Ophthalmic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Ophthalmic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Ophthalmic Drugs Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Ophthalmic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Ophthalmic Drugs Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Ophthalmic Drugs Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Ophthalmic Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Ophthalmic Drugs Sales Share by Players/Suppliers
Figure 2017 United States Ophthalmic Drugs Sales Share by Players/Suppliers
Figure United States Ophthalmic Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Ophthalmic Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Ophthalmic Drugs Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Ophthalmic Drugs Revenue Share by Players/Suppliers
Figure 2017 United States Ophthalmic Drugs Revenue Share by Players/Suppliers
Table United States Market Ophthalmic Drugs Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Ophthalmic Drugs Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Ophthalmic Drugs Market Share of Top 3 Players/Suppliers
Figure United States Ophthalmic Drugs Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Ophthalmic Drugs Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Ophthalmic Drugs Product Category
Table United States Ophthalmic Drugs Sales (K Pcs) by Region (2012-2017)
Table United States Ophthalmic Drugs Sales Share by Region (2012-2017)
Figure United States Ophthalmic Drugs Sales Share by Region (2012-2017)
Figure United States Ophthalmic Drugs Sales Market Share by Region in 2016
Table United States Ophthalmic Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Ophthalmic Drugs Revenue Share by Region (2012-2017)
Figure United States Ophthalmic Drugs Revenue Market Share by Region (2012-2017)
Figure United States Ophthalmic Drugs Revenue Market Share by Region in 2016
Table United States Ophthalmic Drugs Price (USD/Pcs) by Region (2012-2017)
Table United States Ophthalmic Drugs Sales (K Pcs) by Type (2012-2017)
Table United States Ophthalmic Drugs Sales Share by Type (2012-2017)
Figure United States Ophthalmic Drugs Sales Share by Type (2012-2017)
Figure United States Ophthalmic Drugs Sales Market Share by Type in 2016
Table United States Ophthalmic Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Ophthalmic Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Ophthalmic Drugs by Type (2012-2017)
Figure Revenue Market Share of Ophthalmic Drugs by Type in 2016
Table United States Ophthalmic Drugs Price (USD/Pcs) by Types (2012-2017)
Figure United States Ophthalmic Drugs Sales Growth Rate by Type (2012-2017)
Table United States Ophthalmic Drugs Sales (K Pcs) by Application (2012-2017)
Table United States Ophthalmic Drugs Sales Market Share by Application (2012-2017)
Figure United States Ophthalmic Drugs Sales Market Share by Application (2012-2017)
Figure United States Ophthalmic Drugs Sales Market Share by Application in 2016
Table United States Ophthalmic Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Ophthalmic Drugs Sales Growth Rate by Application (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Ophthalmic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer Ophthalmic Drugs Sales Growth Rate (2012-2017)
Figure Pfizer Ophthalmic Drugs Sales Market Share in United States (2012-2017)
Figure Pfizer Ophthalmic Drugs Revenue Market Share in United States (2012-2017)
Table Merck Basic Information List
Table Merck Ophthalmic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Merck Ophthalmic Drugs Sales Growth Rate (2012-2017)
Figure Merck Ophthalmic Drugs Sales Market Share in United States (2012-2017)
Figure Merck Ophthalmic Drugs Revenue Market Share in United States (2012-2017)
Table Glaxosmithkline Basic Information List
Table Glaxosmithkline Ophthalmic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Glaxosmithkline Ophthalmic Drugs Sales Growth Rate (2012-2017)
Figure Glaxosmithkline Ophthalmic Drugs Sales Market Share in United States (2012-2017)
Figure Glaxosmithkline Ophthalmic Drugs Revenue Market Share in United States (2012-2017)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Ophthalmic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Abbott Laboratories Ophthalmic Drugs Sales Growth Rate (2012-2017)
Figure Abbott Laboratories Ophthalmic Drugs Sales Market Share in United States (2012-2017)
Figure Abbott Laboratories Ophthalmic Drugs Revenue Market Share in United States (2012-2017)
Table Johnson and Johnson Basic Information List
Table Johnson and Johnson Ophthalmic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Johnson and Johnson Ophthalmic Drugs Sales Growth Rate (2012-2017)
Figure Johnson and Johnson Ophthalmic Drugs Sales Market Share in United States (2012-2017)
Figure Johnson and Johnson Ophthalmic Drugs Revenue Market Share in United States (2012-2017)
Table Bayer Basic Information List
Table Bayer Ophthalmic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bayer Ophthalmic Drugs Sales Growth Rate (2012-2017)
Figure Bayer Ophthalmic Drugs Sales Market Share in United States (2012-2017)
Figure Bayer Ophthalmic Drugs Revenue Market Share in United States (2012-2017)
Table Shire Basic Information List
Table Shire Ophthalmic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Shire Ophthalmic Drugs Sales Growth Rate (2012-2017)
Figure Shire Ophthalmic Drugs Sales Market Share in United States (2012-2017)
Figure Shire Ophthalmic Drugs Revenue Market Share in United States (2012-2017)
Table Roche Holding Basic Information List
Table Roche Holding Ophthalmic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Roche Holding Ophthalmic Drugs Sales Growth Rate (2012-2017)
Figure Roche Holding Ophthalmic Drugs Sales Market Share in United States (2012-2017)
Figure Roche Holding Ophthalmic Drugs Revenue Market Share in United States (2012-2017)
Table Novartis Basic Information List
Table Novartis Ophthalmic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Novartis Ophthalmic Drugs Sales Growth Rate (2012-2017)
Figure Novartis Ophthalmic Drugs Sales Market Share in United States (2012-2017)
Figure Novartis Ophthalmic Drugs Revenue Market Share in United States (2012-2017)
Table Akorn Basic Information List
Table Akorn Ophthalmic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Akorn Ophthalmic Drugs Sales Growth Rate (2012-2017)
Figure Akorn Ophthalmic Drugs Sales Market Share in United States (2012-2017)
Figure Akorn Ophthalmic Drugs Revenue Market Share in United States (2012-2017)
Table Eyemed Basic Information List
Table Senju Pharmaceutical Basic Information List
Table Sun Pharmaceuticals Industries Basic Information List
Table Allergan Basic Information List
Table Valeant Basic Information List
Table Regeneron Basic Information List
Table Eyegate Pharmaceuticals Basic Information List
Table Lpath Incorporated Basic Information List
Table Santen Pharmaceutical Basic Information List
Table Cipla Pharmaceuticals Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Ophthalmic Drugs
Figure Manufacturing Process Analysis of Ophthalmic Drugs
Figure Ophthalmic Drugs Industrial Chain Analysis
Table Raw Materials Sources of Ophthalmic Drugs Major Players/Suppliers in 2016
Table Major Buyers of Ophthalmic Drugs
Table Distributors/Traders List
Figure United States Ophthalmic Drugs Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Ophthalmic Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Ophthalmic Drugs Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Ophthalmic Drugs Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Ophthalmic Drugs Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Ophthalmic Drugs Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Ophthalmic Drugs Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Ophthalmic Drugs Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Ophthalmic Drugs Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Ophthalmic Drugs Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Ophthalmic Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Ophthalmic Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Ophthalmic Drugs Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources